chitosan has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HJ; Byeon, Y; Han, HD; Jang, JH; Jeon, HN; Jung, ID; Kang, TH; Kim, GH; Kim, MG; Lee, JW; Lee, YJ; Lim, YT; Pack, CG; Park, YM; Shin, BC; Sood, AK | 1 |
| Gunn, J; Park, SI; Press, OW; Veiseh, O; Zhang, M | 1 |
2 other study(ies) available for chitosan and Lymphoma
| Article | Year |
|---|---|
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Antigen Presentation; Antigens; Cancer Vaccines; Cell Line, Tumor; Cell Proliferation; Chitosan; Dendritic Cells; Female; Gene Expression; Immunomodulation; Immunotherapy; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred C57BL; Nanoparticles; Nanotechnology; Ovalbumin; Poly I-C; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 3; Transfection | 2016 |
A pretargeted nanoparticle system for tumor cell labeling.
Topics: Biotin; Cell Line, Tumor; Chitosan; Ferric Compounds; Humans; Leukemia; Ligands; Lymphoma; Nanoparticles; Polyethylene Glycols; Recombinant Fusion Proteins; Staining and Labeling | 2011 |